Cortex
Volume 45, Issue 7 , Pages 900-903 , July 2009

Antisaccade performance in patients with multiple sclerosis

  • Joanne Fielding

      Affiliations

    • Centre for Neuroscience, University of Melbourne, Parkville, Victoria, Australia
    • Centre for Developmental Psychiatry and Psychology, School of Psychology, Psychiatry, and Psychological Medicine, Monash University, Clayton, Victoria, Australia
    • Department of Neurology, Royal Melbourne Hospital, Parkville, Victoria, Australia
    • Corresponding Author InformationCorresponding author. Centre for Neuroscience, University of Melbourne, Grattan St, Parkville, Victoria 3050, Australia.
  • ,
  • Trevor Kilpatrick

      Affiliations

    • Centre for Neuroscience, University of Melbourne, Parkville, Victoria, Australia
    • Department of Neurology, Royal Melbourne Hospital, Parkville, Victoria, Australia
  • ,
  • Lynette Millist

      Affiliations

    • Department of Neurology, Royal Melbourne Hospital, Parkville, Victoria, Australia
  • ,
  • Owen White

      Affiliations

    • Centre for Developmental Psychiatry and Psychology, School of Psychology, Psychiatry, and Psychological Medicine, Monash University, Clayton, Victoria, Australia
    • Department of Neurology, Royal Melbourne Hospital, Parkville, Victoria, Australia

Received 20 October 2008 ,Revised 16 February 2009 ,Accepted 27 February 2009.

References 

  1. Beck A, Steer RA. The Beck Depression Inventory (Manual). New York: Psychological Corporation; 1991;
  2. Bobholz JA, Rao SM, Lobeck L, Elsinger C, Gleason A, Kanz J, et al. fMRI study of episodic memory in relapsing-remitting MS: correlation with T2 lesion volume. Neurology. 2006;67:1640–1645
  3. Braun D, Weber H, Mergner T, Schulte-Monting J. Saccadic reaction times in patients with frontal and parietal lesions. Brain. 1992;15:1359–1386
  4. Calabrese P. Neuropsychology of multiple sclerosis: an overview. Journal of Neurology. 2006;253(Suppl 1):I/10–I/15
  5. Ettinger U, Ffytche D, Kumari V, Kathmann N, Reuter B, Zelaya F, et al. Decomposing the neural correlates of antisaccade eye movements using event-related fMRI. Cerebral Cortex. 2008;18:1148–1159
  6. Fielding J, Kilpatrick T, Millist L, White O. Multiple sclerosis: cognition and saccadic eye movements. Journal of the Neurological Sciences. 2009;277:32–36
  7. Fielding J, Kilpatrick T, Millist L, and White O. Control of visually guided saccades in multiple sclerosis: disruption to higher order processes. Neuropsychologia, in press.
  8. Frohman EM, Frohman TC, Zee DS, McColl R, Galetta S. The neuro-ophthalmology of multiple sclerosis. Lancet Neurology. 2005;4:111–121
  9. Heitger MH, Anderson TJ, Jones RD, Dalrymple-Alford JC, Frampton CM, Ardagh MW. Eye movement and visuomotor arm movement deficits following mild closed head injury. Brain. 2004;127:575–590
  10. Hutton SB, Ettinger U. The antisaccade task as a research tool in psychopathology: a critical review. Psychophysiology. 2006;43:301–313
  11. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983;33:
  12. Manoach D, Ketwaroo G, Polli F, Thakkar K, Barton J, Goff D, et al. Reduced microstructural integrity of the white matter underlying anterior cingulate cortex is associated with increased saccadic latency in schizophrenia. Neuroimage. 2007;37:710–716
  13. Nelson HE. The National Adult Reading Test (NART): Test Manual. Windsor, UK: NFER-Nelson; 1982;
  14. Pierrot-Deseilligny C, Milea D, Müri RM. Eye movement control by the cerebral cortex. Current Opinion in Neurology. 2004;17:17–25
  15. Ploner CJ, Gaymard B, Rivaud-Pechoux S, Pierrot-Deseilligny C. The prefrontal substrate of reflexive saccade inhibition in humans. Biological Psychiatry. 2005;57:1159–1165
  16. Rivaud S, Müri RM, Gaymard B, Vermersch AI, Pierrot-Deseilligny C. Eye movement disorders after frontal eye field lesions in humans. Experimental Brain Research. 1994;102:110–120
  17. Rovaris M, Comi G, Filippi M. MRI markers of destructive pathology in multiple sclerosis-related cognitive dysfunction. Journal of the Neurological Sciences. 2006;245:111–116
  18. Sartori E, Edan G. Assessment of cognitive dysfunction in multiple sclerosis. Journal of the Neurological Sciences. 2006;245:169–175
  19. Schulz D, Kopp B, Kunkel A, Faiss JH. Cognition in the early stage of multiple sclerosis. Journal of Neurology. 2006;253:1002–1010

PII: S0010-9452(09)00092-6

doi: 10.1016/j.cortex.2009.02.016

Cortex
Volume 45, Issue 7 , Pages 900-903 , July 2009